NEW YORK(GenomeWeb) – Agilent Technologies and Cartagenia said today that Agilent will acquire Cartagenia for an undisclosed sum.

The acquisition will provide Agilent with software solutions for its clinical genetics and molecular oncology customers, while providing stronger support and services for Cartagenia's clients, Jacob Thaysen, president of Agilent's Diagnostics and Genomics Group, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.